Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ELDNELDN
Showing 8 of 13 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ELEDON PHARMACEUTICALS INC

Yes. Bank of America holds 883,097 shares of ELDN (Eledon Pharmaceuticals), worth $3.5M, as of its Q2 2026 13F filing. It increased the position by 13,553 shares (+1.6%) from Q1 2026. Bank of America has held ELDN since Q2 2024, across 9 quarterly 13F filings.

Current Value

$3.5M

Current Shares

883,097

Total Value Change

+$3.5M

Total Shares Change

+876,281

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
883,097
+1.6%
$3.5M0.0%$3.94
27
2026-Q1
Increased
869,544
+1346.9%
$2.7M0.0%$2.50
42
2025-Q4
Increased
60,098
+32.9%
$90,7480.0%$1.51
19
2025-Q3
Increased
45,229
+78.3%
$117,1440.0%$2.54
23
2025-Q2
Increased
25,367
+261.8%
$68,7450.0%$2.69
23
2025-Q1
Decreased
7,012
-92.6%
$23,7710.0%$3.35
0
2024-Q4
Increased
95,142
+1295.9%
$391,9850.0%$4.14
26
2024-Q3
Decreased
6,816
-0.0%
$16,9720.0%$2.49
0

Other major holders of ELDN: BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., FMR LLC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used